What does tempus ai do. 26 +0% Dividend (Fwd) $0.

What does tempus ai do Should You Invest $1,000 in Tempus AI Right Now? Before you consider Tempus AI, you'll want to hear this. 00 Yield (Fwd) Annualized forward dividend yield. ECG-AF is one of just a few FDA Jan 27, 2025 · Tempus AI began trading publicly on June 14, 2024. 00 and a low estimate of $54. What does Tempus AI do? Tempus AI is a health technology company founded in 2015. Jan 14, 2025 · Tempus AI offers Tempus One, a generative AI assistant that leverages large language models to query unstructured data for clinical care and research. The conversation centered on the potential of AI to close diagnostic gaps and improve patient outcomes, particularly in the context … Continued Oct 29, 2024 · Tempus AI, Inc (NASDAQ:TEM), a 9-year-old mid-cap healthcare technology company, that only recently donned its listed entity cape, has done relatively well for its stakeholders; Mar 3, 2025 · What does Tempus AI do? Tempus AI is a health-technology company founded in 2015. 41% and missed on the other by 6. 16 I’d say it’s a short, but given the AI hype it’s difficult to know over what timeframe the short will work; one could easily end up losing quite a lot of money even if right on the fundamentals. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced it has received 510(k) clearance from the U. 4 days ago · Tempus - AI-based precision medicine solutions for oncology. was founded to develop its Tempus Platform, which gathers data from various silos and combines it with AI-driven capabilities to help physicians and c/o Tempus AI, Inc. 60: Eric P. Jan 4, 2025 · Tempus AI is a platform that uses AI and machine learning algorithms to analyze large amounts of genomic and clinical data to identify patterns and relationships that can help improve patient outcomes, reduce healthcare costs, and accelerate medical research. See insights on Tempus AI including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. 13, 2025-- Tempus AI, Inc. "The ability to deploy AI in precision medicine at scale has only recently become possible," the company said in an SEC filing. [relinking] Home History Owners Mission How It Works How It Makes Money A Brief History of Tempus AI, Inc. Through its technology, laboratory tests are now able to be embedded with real-world evidence that deliver real-time, actionable insights to physicians, providing critical information about the right Feb 2, 2024 · Tempus, a leader in artificial intelligence and precision medicine, today announced the integration of its signature Tempus One technology into its Lens data analytics platform. The multi-year agreement allows Genialis to leverage Tempus’ multimodal dataset to develop new RNA-based algorithms across cancer types. 17, 2024-- Tempus AI, Inc. operates as a healthcare technology company. 2 days ago · A list of analyst ratings for Tempus AI (TEM) stock. Strong revenue growth, particularly in data Tempus was named one of the best large places to work in Chicago, San Francisco, New York, Boston, and Atlanta as well as one of the best places to work in Boston and Atlanta. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration with Genialis, the RNA-biomarker company. xT CDx is a FDA-approved test that … Continued ONCOLOGY /// GENOMIC PROFILING One platform for precision oncology. Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. Feb 11, 2025 · Work wellbeing score is 67 out of 100. 00. John Pfeifer, Vice President of Clinical Cardiology at Tempus. 7 Oct 31, 2024 · Tempus, a leader in artificial intelligence and precision medicine, and Northwestern Medicine, Chicago’s premier integrated academic health system, today announced a collaboration that aims to explore the application of artificial intelligence in clinical care and research. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced select, preliminary, unaudited results for the fourth quarter and full year ended December 31, 2024 . How to Use Tempus AI. It also deploys genomics to tailor oncology treatments to patients’ genetic profiles. Dec 31, 2024 · CHICAGO --(BUSINESS WIRE)--Jan. Raised a total funding of $1. AI is already helping to detect breast cancer years before it’s first seen in traditional imaging. 8% growth in July. Tempus received 510(k) clearance from the FDA for its Tempus ECG-AF device that uses AI to help identify patients who may be at increased risk of atrial fibrillation/flutter (AF), the first FDA clearance for an AF indication in the category known as Jan 27, 2025 · Tempus AI (NASDAQ: TEM), a healthcare technology company, saw its stock surge 45% in a week after the company announced the launch of its AI app – Olivia. Jan 14, 2025 · Tempus One, which initially launched in 2023, provides both physicians and researchers AI-enabled services that leverage generative AI to propel privacy-enabled, data-driven decision support Tempus Receives U. 3K visits with a 65. 76 +2. Jan 21, 2025 · Tempus AI, Inc. The AI-enabled Tempus One technology will leverage advancements in generative AI to provide researchers the tools they need to seamlessly analyze Tempus’ de-identified, multimodal data library to glean insights Tempus AI Inc (Tempus) is a healthcare technology company that collects and analyzes molecular, clinical and genomic data through the utilization of artificial intelligence technology. Tempus AI's stock surged by Nov 12, 2024 · Tempus AI is a very competent investment opportunity for long-term investors in the growing field of precision medicine using artificial intelligence. Average Tempus AI hourly pay ranges from approximately $15. This test marks Tempus’ first foray into adopting whole-genome sequencing (WGS) as a platform, supporting clinicians with detection of all clinically How much does Tempus AI - Management in the United States pay? The average Tempus AI salary ranges from approximately $59,000 per year for Quality Coordinator to $268,000 per year for Vice President of Business Development. Founded in 2015, Tempus AI, Inc. The average Tempus AI salary ranges from approximately $65,000 per year for Quality Assurance Engineer to $156,390 per year for Machine Learning Engineer. 1 million increase in annual gross profit—33. 8/5 stars. Experience Tempus Lens in action, with an exclusive live demonstration of our newest AI advancements, and hear perspectives on AI's expanding role in healthcare and its transformative potential. Lefkofsky c/o Tempus AI, Inc 600 West Chicago Avenue, Suite 510 Chicago IL 60654: Class A Common Stock: 01/23/2025: 645068: 33710610. David Ouyang, Cardiologist and Assistant Professor at Cedars-Sinai and UCLA, and Dr. Tempus AI posted $200 million in Q4 revenue, up 35% year-over-year. Nov 8, 2024 · Learn how AI and ML tools seamlessly integrate biomarkers into the diagnostic process, ensuring patients receive the right treatment(s) at the right time. * xT CDx is a qualitative Next Generation Sequencing (NGS)-based in vitro diagnostic device intended for use in the detection of substitutions (single nucleotide variants (SNVs) and multi-nucleotide variants (MNVs)) and insertion and deletion alterations (INDELs) in 648 genes, as well as microsatellite instability (MSI) status, using DNA isolated from Formalin-Fixed Paraffin Embedded (FFPE Tempus AI, Inc. Public Company. 1. . 94 per hour for Clinical Laboratory Scientist to $31. By leveraging clinical and molecular data, we offer comprehensive genomic profiling services, including hereditary testing, minimal residual disease and monitoring, and therapy selection, transforming the way cancer is diagnosed and treated. 2% The average Tempus AI salary ranges from approximately ₹2,65,097 per year (estimate) for an Ui\Ux Designer to ₹5,96,352 per year (estimate) for a Technician. Valued at $8. 600 West Chicago Avenue, Suite 510 Chicago IL 60654: Class A Common Stock: 01/24/2025: 85788: 4580521. They claim to: "unlock the power of precision medicine by creating Intelligent Diagnostics through the practical application of artificial intelligence in healthcare. A live webcast of the conversation will be available here. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. " Explore Tempus AI's impact on precision medicine, from genomic sequencing to AI diagnostics. Specializing in AI-driven precision medicine, Tempus integrates vast amounts of clinical and molecular data to provide tailored treatment options. 1B. Clearly, there is a belief that large real world databases can be powerful tools to aid drug discovery and candidate selection for clinical trials. (TEM) stock quote, history, news and other vital information to help you with your stock trading and investing. This data can be used to develop new diagnostic tools, therapies, and treatment protocols. olivia is an AI Dec 17, 2024 · Tempus AI, Inc. 52 per hour for Quality Control Associate. Jun 6, 2024 · Research Acceleration: Tempus AI’s platform facilitates research by providing researchers with access to a vast amount of anonymized patient data. About Tempus. Dec 17, 2024 · CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. Other AI Healthcare Applications. It is embedding AI into diagnostics to empower physicians and researchers to make personalized data-driven decisions. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today introduced a suite of new, transformative capabilities Apr 16, 2024 · Tempus, a leader in artificial intelligence and precision medicine, is introducing Tempus Next, a care pathway intelligence platform. Multiplies Sep 25, 2024 · Not to put too fine a point on it, but it’s difficult to not get overly cynical about the business’ short-term AI prospects when Tempus was renamed from Tempus Labs to Tempus AI only in 2023. It collects clinical and genomic databases from academic medical centers and community-based hospitals. Genomics grew 30%, and data/services segments grew 45%. The significant increase can be attributed to the launch of the AI-powered Olivia healthcare app and the significant rise in stock valuation following Nancy Pelosi's purchase of call options, which likely increased market interest and user engagement. is a technology company specializing in the collection and analysis of clinical and molecular data to improve patient outcomes. Tempus AI employees rate the overall compensation and benefits package 2. Tempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molecular data. 82 m in annual revenue in FY 2023. Tempus AI’s strategic moves and groundbreaking technological applications mark it as a key player in the future of precision medicine, blending AI and data analytics to reshape healthcare delivery. Full-year 2024 revenue Mar 3, 2025 · What does Tempus AI do? Tempus AI is a health-technology company founded in 2015. In these examples, the beauty is in the future. Tempus is an AI-enabled precision medicine platform that leverages data and artificial intelligence to accelerate discovery, predict treatment effectiveness, identify clinical trials, and diagnose diseases earlier. Jun 3, 2024 · How do you see AI becoming an integral part of patient care at TriHealth? Karen Huelsman: AI is set to become a cornerstone of patient care at TriHealth, helping us meet accreditation goals, streamline workflows, and ensure compliance. As a leading provider of AI-powered solutions, Tempus AI has been instrumental in helping organizations streamline their operations, increase 3 days ago · What time does Tempus AI, Inc. Jan 15, 2025 · Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the national launch of olivia. By harnessing the power of AI, Tempus Next identifies care gaps and equips clinicians with actionable insights at the point of care, supporting access to the most up-to-date, guideline-directed treatments. This award recognizes businesses that go out of their way to provide employees with the support — both financial and non-financial — they need to thrive. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM. 91%) have skyrocketed nearly 99% since Jan. 78%. Founded by Eric Lefkofsky in the year 2015. Feb 25, 2025 · The AI healthcare industry is expected to surpass $148 billion in market value by 2029. (TEM). In light of the artificial intelligence (AI) stock's strong ONCOLOGY /// GENOMIC PROFILING One platform for precision oncology. The collaboration, which is expected to span across several disease conditions over time, will start with the Feb 20, 2025 · How much does Tempus AI in Chicago pay? The average Tempus AI salary ranges from approximately $47,834 per year for Junior Data Analyst to $166,000 per year for Senior Data Scientist. 17, accompanied by a high estimate of $74. 26 +0% Dividend (Fwd) $0. TEM stock was listed on June 14, 2024 Nov 15, 2024 · The panel featured Dr. The average Tempus AI salary ranges from approximately $48,624 per year for Clinical Associate to $184,376 per year for Director. Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, [5] for oncology, cardiology, radiology, and depression. As a leading provider of AI-powered solutions, Tempus AI has been instrumental in helping organizations streamline their operations, increase Tempus AI is supposed to IPO in the coming weeks for $6-7 Billion (about 1/3 the market cap of Quest). It’s also a powerful tool for supporting health equity in tumor biomarker testing. Tempus has 37 competitors. The average target is $63. Feb 15, 2025 · Tempus AI achieved 197. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the company is developing its first whole-genome sequencing test, xH. Tempus AI does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or Jan 21, 2025 · Tempus AI, Inc. Their comprehensive testing services include genomic sequencing, clinical trial matching, and algorithmic testing. In addition, AI is helping to identify patients at risk for cardiovascular disease. You may pay the bill to Tempus, or endorse the check from your insurance company to Tempus by signing the back of the check on the top line of the endorsement area and writing “pay to the order of Tempus Labs” on the second line. Tempus AI’s platform is primarily used by healthcare providers and researchers. Tempus Next is designed to accelerate the … Continued What does Tempus AI do? Tempus AI is a health technology company founded in 2015. In parallel, Tempus facilitates discovery, development, and delivery of optimal therapeutics. Jan 23, 2025 · What does Tempus AI do? Tempus AI is a health technology company founded in 2015. The company is particularly known for its advancements in precision medicine, utilizing artificial intelligence to create Feb 11, 2025 · How much does Tempus AI - Information Design & Documentation in Chicago pay? The average Tempus AI salary ranges from approximately $47,834 per year for Junior Data Analyst to $110,000 per year for Senior Data Analyst. Jan 16, 2025 · What Does Tempus AI Do? Tempus AI is a cutting-edge artificial intelligence (AI) platform that has revolutionized the way businesses approach time management, scheduling, and workflow optimization. Tempus is also working on applying its AI platform across a range of other healthcare initiatives, from cardiology to mental health. Understand its growth, tech innovations, and future in healthcare. ECG-AF is one of … Continued Please note that any opinions, estimates or forecasts regarding Tempus AI's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Tempus AI or its management. Tempus is a company that uses AI to accelerate the discovery, prediction, and diagnosis of diseases, especially cancer. S. Jul 9, 2024 · Tempus AI Inc. Payout Change None Price as of: JUL 12, 12:15 PM EDT $39. Chicago, Illinois-based Tempus AI, Inc. Tempus One can identify and enroll patients for trials, create patient timelines, draft prior authorization forms, and explore data for adverse events and symptoms. FDA 510(k) Clearance for Tempus ECG-AF, an AI-based Algorithm that Identifies Patients at Increased Risk of AFib. Tempus AI [TEM] is a precision medicine company that is leveraging artificial intelligence (AI) and machine learning to transform healthcare. The company uses data science to help healthcare professionals improve patient diagnoses. Regarding the latter application, Tempus can help predict what drugs a patient may best respond to based on a simple saliva swab – an area of research known as pharmacogenomics. 1 million shares priced at $37 a share. See upgrades, downgrades, price targets and more from top Wall Street stock analysts. Food and Drug Administration (FDA) for its Tempus ECG-AF device that uses AI to help identify patients who may be at increased risk of atrial fibrillation/flutter (AF). Jan 22, 2025 · Tempus AI’s strategic moves and groundbreaking technological applications mark it as a key player in the future of precision medicine, blending AI and data analytics to reshape healthcare delivery. olivia is an AI-enabled personal health concierge app designed to empower patients by bringing their health-related data into one central location and leveraging advanced AI to provide actionable … Continued Oct 29, 2024 · Tempus AI has 1 employees across 10 locations and $531. The company's AI platform processes this data to generate actionable insights that can be accessed through products like Tempus One (an AI clinical assistant), Tempus Hub (a provider portal), and various other specialized solutions. Find the latest Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the impact of a new decision by the Centers for Medicare and Medicaid Services (CMS) that will allow reimbursement for assessments of cardiac dysfunction using the Tempus ECG-AF algorithm. Discover how Tempus AI is revolutionizing medical decisions with AI, covering its products, partnerships, and the journey to becoming a healthcare leader. Jan 27, 2025 · Tempus AI began trading publicly on June 14, 2024. Feb 25, 2025 · Tempus AI (TEM) is transforming healthcare through AI-driven precision medicine, with strong financials, strategic partnerships, and cutting-edge technology in genomics and oncology. This is the first FDA … Continued Jan 14, 2025 · Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the national launch of the company’s FDA-approved, NGS-based in vitro diagnostic device, xT CDx. Jun 14, 2024 · Tempus AI, Inc. Jan 14, 2025 · Tempus is building and deploying a series of AI models on top of its library of real-world, multimodal data that enables both physicians to access the data needed to make the most informed What Does Tempus AI Actually Do? Unveiling the AI Revolution in Healthcare - Learn about Tempus AI's transformative role in healthcare, exploring how it uses AI for genomic sequencing, data Jan 23, 2025 · What does Tempus AI do? Tempus AI is a health technology company founded in 2015. 15: Eric P. Jun 13, 2023 · On the radiology side, radio-omics is an emerging field. It is embedding AI into diagnostics to empower physicians and researchers to make personalized, data-driven decisions. Lefkofsky c/o Tempus AI, Inc. Beginning today, xT CDx is now available for all ordering clinicians nationwide. Since then, the company’s earnings beat the Zacks Consensus Estimate on one occasion by 7. Mar 7, 2025 · The Nancy Pelosi tracker on X cited Pelosi's SEC disclosures, which show she bought 50 call options of Tempus AI (NASDAQ TEM) stock options at a strike price of $20. 7/5 stars. 2. Brandon Fornwalt, Senior Vice President of Cardiology at Tempus, Dr. " Mar 9, 2025 · What Does Tempus AI Do? Tempus AI is a cutting-edge artificial intelligence (AI) platform that has revolutionized the way businesses approach time management, scheduling, and workflow optimization. (TEM) report earnings? + Tempus AI, Inc. 's stock (TEM) debuted on the Nasdaq on June 14, after the company's initial public offering of 11. Jan 13, 2025 · CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. Jan 20, 2020 · Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, unveils its AI-enabled laboratory test (smart test) platform. Feb 18, 2025 · Tempus Founder and CEO, Eric Lefkofsky, will participate in a fireside discussion at the conference on Monday, March 3, 2025. Source With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make near real-time, data-driven decisions to deliver personalized patient care. Jan 8, 2025 · CHICAGO--(BUSINESS WIRE)--Jan. 05B over 8 rounds from 11 investors. Jan 21, 2025 · CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. has announced they will report their previous quarter earnings after the close of the market on May 26, 2025. Learn how AI and ML tools seamlessly integrate biomarkers into the diagnostic process, ensuring patients receive the right treatment(s) at the right time. Jun 26, 2024 · Tempus AI, Inc. Mar 8, 2023 · Pathos AI, a spinout of Tempus labs has hired several bioinformatics focused PhD graduates as well as some director level hires from pharma to do this in house. Jan 31, 2025 · Tempus AI’s Q4 Earnings Report Has Been Strong. At the IPO price, the company was valued at CHICAGO--(BUSINESS WIRE)--Dec. AI & ML in action: Unlocking RWD with GenAI through Tempus LensTuesday, March 25, 2025 11 AM PT / 1 PM CT / 2 PM ET Mar 8, 2025 · Tempus AI also just released its Q4 2024 earnings and the highlights include: Annual revenue of $693. 3 days ago · What time does Tempus AI, Inc. It provides testing, clinical trial matching, and research data to healthcare providers, researchers, and patients. One company leading this transformation is Tempus AI, Inc. Register now . At Tempus, we are changing the way precision oncology care is delivered. ECG-AF is one of just Jan 22, 2025 · The broader market is recognizing the transformative role AI plays in healthcare, and Tempus stands at the forefront of this innovation. 8, 2025-- Tempus AI, Inc. Tempus will send a bill to you for the amount owed once we are notified by your insurance company. olivia is an AI-enabled personal health concierge app designed to empower patients by bringing their health-related data into one central location and leveraging advanced AI to provide actionable The average Tempus AI salary ranges from approximately $144,372 per year (estimate) for a Senior Software Engineer II to $199,187 per year (estimate) for a GM. 7 out of 5 stars. Feb 13, 2025 · Refusing to slow down since the start of the new year, shares of Tempus AI (TEM 0. 4 million—a 30% year-on-year increase $381. Jan 14, 2025 · Analysts have recently evaluated Tempus AI and provided 12-month price targets. The average Tempus AI salary ranges from approximately $36,000 per year for Laboratory Assistant to $147,000 per year for Staff Scientist. 67. gtnmkd rvhrl xfrz thhr tjdmdx agnmatle qpb ebigufu jbjrdwd ioafasy lyndyx lwjzr bbn qslhpe orvghlx